Retinal Consultants of Southern California physicians have participated in the following clinical trials:
- Branch Vein Occlusion Study
- Diabetic Retinopathy Vitrectomy Study
- Early Treatment of Diabetic Retinopathy Study
- Silicone Oil Study
- Prophylactic Treatment of Age Related Macular Degeneration Study
- Diode Laser for Melanocytic Lesion Study
- Collaborative Ocular Melanoma Study
- SAILOR Study of Lucentis for Age Related Macular Degeneration
- AREDS II for Age Related Macular Degeneration
We are currently participating in the following clinical trials:
- Diabetic Retinopathy Clinical Research Network Protocol N: An Evaluation of Intravitreal Hemorrhage Due to Proliferative Diabetic Retinopathy
- VGFT-OD-0910: An Open Label, Long-Term, Safety and Tolerability Extension Study of Intravitreal VEGF Trap-Eye in Neovascular Age Related Macular Degeneration
- HARBOR Study: DNA Repository Substudy in Association with Ranibizumab Study FVF4579g: A Phase 3, Double-Masked Multicenter, Randomized, Active Treatment-Controlled Study of the Efficacy and Safety of 0.5-mg and 2.0-mg Ranibizumab Administered monthly or on an as needed basis (prn) with a Safety run-in of a Single Dose of a 2.0-mg Ranibizumab in Patients with a Sub Foveal Neovascular Age Related Macular Degeneration
- VGFT-OD-0702: An Open Label, Long Term, Safety and Tolerability Study of Intravitreal VEGF-Trap in Subjects with a Neovascular Age Related Macular Degeneration
- Protocol FVF4170gRISE: A Phase 3, Double-Masked, Multicenter, Randomized, Sham-Controlled Study of the Efficacy and Safety of Ranibizumab Injection in Subjects with Clinically Significant Macular Edema with Center Involvement Secondary to Diabetes Mellitus
